Polar Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-175,000
Closed -$3.07M 300
2020
Q2
$3.07M Sell
175,000
-25,000
-13% -$438K 0.03% 218
2020
Q1
$2.94M Hold
200,000
0.03% 228
2019
Q4
$5.02M Buy
200,000
+109,618
+121% +$2.75M 0.04% 235
2019
Q3
$1.36M Sell
90,382
-9,618
-10% -$145K 0.01% 258
2019
Q2
$2.5M Buy
+100,000
New +$2.5M 0.02% 251